Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition. - Wikidata - wikimedia - TriplyDB

Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.

Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.

http://www.wikidata.org/entity/Q35180335

about

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome.[Mechanisms of resistance to EML4-ALK inhibitors in non-small cell lung cancer].

P2860

Q26849503-21B6902F-2DDC-47A2-A8B7-BA2730ADA161 Q47102779-70482D20-C066-4279-AF0B-8E81FA892402 Q55429137-03B3F551-DB52-4B7D-B9AF-1BF90E068F18

P2860

Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.

http://www.wikidata.org/entity/Q35180335

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@ast

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@en

type

label

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@ast

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@en

prefLabel

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@ast

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@en

P1433

Q35180335-08E29913-05BD-4EAA-9C88-7350AB07D2BC

P1476

Q35180335-7C49A3B9-0CA8-4535-86A1-A1F3FC49A7F7

P2093

Q35180335-41AE611F-9DDD-4211-9057-B68351254ECE

Q35180335-9AEB9C61-1FE8-4E9B-9E45-95CBE3E92CCA

Q35180335-BBB896DF-E933-41B8-9517-7045C8776262

Q35180335-BEB02E72-D410-4FB2-83F2-BFBFC4FEE559

Q35180335-C3EA9DBD-C865-4E23-90FD-0EB120A0C825

Q35180335-D49F2430-7763-4BBF-AB3B-01ACC78E731F

Q35180335-DF436934-A0C0-4E2E-AC1B-06F18D3E104C

P2860

Q35180335-07053BC7-CDB6-4B42-9F81-970CE4DE7807

Q35180335-0BEF0376-6496-4B03-A901-F490182124C9

Q35180335-0D53832B-06FB-4F41-8FD8-65C656860B35

Q35180335-1B7A0A72-72D1-487F-BFA2-AA1E1D645AA5

Q35180335-26080F4B-129E-473C-A322-64B2088E14AE

Q35180335-280B88D5-45AC-4279-A537-1A0750E8D2DB

Q35180335-2B67C061-88AA-4516-8DE0-07B98DC2ABE1

Q35180335-37C39399-4BBE-44B7-89BF-1845594A3F23

Q35180335-38D974C0-DE18-4407-8046-C1A8CEF0B3CF

Q35180335-58F16459-A4CC-47CE-B406-3940C01815E0

P304

Q35180335-2B06103A-70EF-41E7-B72B-6B194AC4B38F

P31

Q35180335-CADBE177-A6B9-4680-BA91-73DBEA849715

P356

Q35180335-E9F7E1EE-E576-47B1-94F6-FD11F1050023

P433

Q35180335-C1271635-B88A-4FDD-884D-5D87AB2A58F3

P478

Q35180335-B236CD13-86A3-4F92-AE60-E65164703282

P577

Q35180335-AF930A59-4279-4582-9FA1-ADEDB9EA24D3

P5875

Q35180335-5F2F891E-87A6-42C2-9CEE-1B21CE17D45C

P698

Q35180335-B2A339AD-2135-40A0-9DEC-93CA3BAEB096

P932

Q35180335-1F17CD67-159A-4475-9398-E9045A43D96F

P356

1947601911416003

P1433

P1476

Cooperative Cross-Talk between ...... ic Lymphoma Kinase Inhibition.

@en

P2093

Andrew M Chan

http://www.w3.org/2001/XMLSchema#string

Colin R Kennedy

http://www.w3.org/2001/XMLSchema#string

Hong Guan

http://www.w3.org/2001/XMLSchema#string

Jong-In Park

http://www.w3.org/2001/XMLSchema#string

Olena Wiedemeier

http://www.w3.org/2001/XMLSchema#string

Sarah B Tilkens

http://www.w3.org/2001/XMLSchema#string

Xiaocai Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic lymphoma kinase: signalling in development and disease

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

DNA damage-mediated induction of a chemoresistant niche

Identification of ALK as a major familial neuroblastoma predisposition gene

Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Activating mutations in ALK provide a therapeutic target in neuroblastoma.

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

P304

538-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1947601911416003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51627055

http://www.w3.org/2001/XMLSchema#string

P698

21901167

http://www.w3.org/2001/XMLSchema#string

P932

3161418

http://www.w3.org/2001/XMLSchema#string